Module 1. Structure and function of the respiratory system |
1 Anatomy and development (including malformations) |
2 Immunology and defence mechanisms |
Module 2. Physiology and pulmonary function testing |
1 Ventilation (theory) |
2 Circulation (theory) |
3 Control of breathing (theory) |
4 Control of ventilation (theory) |
5 Respiratory mechanics (diagnostics) |
6 Gas exchange (diagnostics) |
7 Arterial blood gas and acid–base status assessment (diagnostics) |
8 Exercise testing (diagnostics) |
9 Bronchial challenge testing (diagnostics) |
10 Lung function tests (interpretation) |
Module 3. Diagnostic approach |
1 Symptoms |
2 Signs |
3 Syndrome based approach to diagnosis and differential diagnosis |
Module 4. Diagnostic procedures |
1 Endoscopic techniques items |
1.1 Bronchoscopy |
1.2 Endobronchial ultrasound (EBUS) and oesophageal ultrasound (EUS) |
1.3 Thoracoscopy |
2 Thoracocentesis including closed pleural biopsy |
3 Imaging techniques |
3.1 Chest radiography |
3.2 Thoracic ultrasound |
3.3 Computed tomography (CT) scan |
3.4 Positron emission tomography (PET) CT |
4 Assessment of airway inflammation |
4.1 Exhaled nitric oxide fraction (FeNO) and nasal nitric oxide (nNO) |
4.2 Sputum assessment |
5. Basic microbiological methods |
Module 5. General principles of treatment modalities and prevention measures |
1 Pharmacotherapy |
1.1 Inhaled drug therapy |
1.2 Systemic pharmacotherapy |
2 Immunotherapy |
2.1 Allergen-specific immunotherapy |
2.2 Lung cancer immunotherapy |
3 Respiratory physiotherapy |
4 Pulmonary rehabilitation |
5 Palliative care |
6 Oxygen therapy |
7 Preventive measures |
8 Smoking prevention and cessation |
9 Assisted ventilation |
10 Chest tube insertion |
11 Advanced treatment modalities |
11.1 Endobronchial interventions |
11.2 Lung volume reduction (surgical and endoscopic lung volume reduction (ELVR)) |
11.3 Lung transplantation |
Module 6. Respiratory emergencies |
1 Evaluation |
2 Differential diagnosis |
3 Immediate management steps |
4 First-line treatment |
5 Specific conditions |
Module 7. Airway diseases |
1 Upper airway diseases |
2 Asthma |
3 Bronchitis |
4 Chronic obstructive pulmonary disease (COPD) and emphysema |
5 Bronchiolitis |
6 Bronchiectasis |
7 Rare airway diseases |
8 Congenital airway disease |
Module 8. Respiratory infections |
1 Upper respiratory tract infections |
2 Lower respiratory tract infections |
3 Pleural infections |
4 Lung abscess and other infections |
5 Influenza, pandemics and severe acute respiratory syndrome (SARS) |
6 Infections in the immunocompromised host |
7 Aspiration pneumonitis |
Module 9. Mycobacterial diseases |
1 Pulmonary tuberculosis (TB) including multidrug-resistant (MDR)/extensively drug resistant (XDR)-TB |
2 Extrapulmonary TB |
3 Latent tuberculous infection |
4 Non-tuberculous mycobacterial diseases |
Module 10. Thoracic tumours |
1 Lung tumours |
1.1 Lung cancer (include paraneoplastic syndromes) |
1.2 Other lung tumours |
1.3 Metastatic pulmonary tumours |
1.4 Solitary nodules |
2 Pleural tumours |
2.1 Mesothelioma |
2.2 Other pleural tumours |
3 Chest wall tumours |
4 Mediastinal tumours |
Module 11. Sleep and control of breathing disorders |
1 Obstructive sleep apnoea syndrome |
2 Central sleep apnoea syndrome |
3 Hypoventilation syndromes |
4 Dysfunctional breathing/hyperventilation syndrome |
Module 12. Respiratory failure |
1 Acute respiratory failure |
2 Chronic respiratory failure |
Module 13. Diffuse parenchymal lung diseases |
1 Hypersensitivity pneumonitis |
2 Sarcoidosis |
3 Idiopathic interstitial pneumonias |
4 Cryptogenic organising pneumonia of unknown aetiology/bronchiolitis obliterans organising pneumonia |
5 Connective tissue disease related interstitial lung disease |
6 Langerhans cell histiocytosis |
7 Lymphangioleiomyomatosis (LAM) |
8 Pulmonary alveolar proteinosis |
9 Amyloidosis |
10 Drug-induced disease |
11 Radiation-induced disease |
12 Nonasthmatic eosinophilic bronchitis |
13 Acute and chronic eosinophilic pneumonia |
14 Hypereosinophilic syndrome |
Module 14. Pulmonary vascular diseases |
1 Thromboembolic disease |
2 Pulmonary hypertension |
3 Vasculitis and diffuse pulmonary haemorrhage |
4 Arteriovenous malformation |
Module 15. Diseases of the chest wall and respiratory muscles including the diaphragm |
1 Chest wall deformities |
2 Neuromuscular disorders |
3 Diaphragmatic disorders |
Module 16. Pleural and mediastinal diseases (excluding tumours) |
1 Pleural effusion |
2 Pneumothorax |
3 Mediastinitis |
Module 17. Respiratory consequences of systemic/ extrapulmonary conditions |
1 Primary immunodeficiency syndromes |
2 Secondary immunodeficiency syndromes/immunosuppression |
3 Cardiac disease |
4 Gastrointestinal, liver and kidney disease |
5 Haematological disease |
6 Obesity |
7 Connective tissue diseases |
Module 18. Genetic disorders |
1 Cystic fibrosis |
2 Primary ciliary dyskinesia |
3 α1-antitrypsin deficiency |
4 Birt–Hogg–Dubé syndrome |
Module 19. Occupational diseases |
1 Respiratory hazards associated with occupational factors |
2 Acute inhalation injuries and their possible sequelae |
3 Occupational respiratory infections including in healthcare workers |
4 Work-related asthma (including occupational asthma and work-exacerbated disease) |
5 COPD and work |
6 Interstitial lung disease (ILD) caused by inorganic agents |
7 ILD caused by dusts of biological origin (including extrinsic allergic alveolitis) |
8 Asbestos-related conditions other than bronchopulmonary cancer (but including mesothelioma) |
9 Occupational causes of bronchopulmonary cancer |
Module 20: Epidemiology, environment and lifestyle |
1 Epidemiological and statistic methods for critical appraisal |
2 Indoor pollution |
3 Outdoor pollution |
4 High-altitude and diving |
5 Lifestyle (smoking, e-cigarettes, nutrition and activity) |